| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
  free 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
  free 
  free 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Disruption of learning processes by chemotherapeutic agents in childhood  survivors of acute lymphoblastic leukemia and preclinical models Bisen-Hersh EB; Hineline PN; Walker EAJ Cancer  2011[]; 2 (ä): 292-301OBJECTIVE: With the survival rate of acute lymphoblastic leukemia (ALL)  surpassing 90 percent within this decade, new research is emerging in the field  of late effects. A review of the research investigating the relationship of  treatment regimens for ALL to specific late effect deficits, underlying  mechanisms, and possible remediation is warranted to support continued studies.  METHODS: The clinical literature was briefly surveyed to describe the occurrence  and topography of late effects, specifically neurocognitive deficits.  Additionally, the preclinical literature was reviewed to uncover potential  underlying mechanisms of these deficits. The advantages of using rodent models to  answer these questions are outlined, as is an assessment of the limited number of  rodent models of childhood cancer treatment. RESULTS: The literature supports  that childhood survivors of ALL exhibit academic difficulties and are more likely  to be placed in a special education program. Behavioral evidence has highlighted  impairments in the areas of attention, working memory, and processing speed,  leading to a decrease in full scale IQ. Neurophysiological and preclinical  evidence for these deficits has implicated white matter abnormalities and  acquired brain damage resulting from specific chemotherapeutic agents commonly  used during treatment. CONCLUSIONS: The exact role of chemotherapeutic agents in  learning deficits remains mostly unknown. Recommendations for an improved rodent  model of learning deficits in childhood cancer survivors are proposed, along with  suggestions for future directions in this area of research, in hopes that  forthcoming treatment regimens will reduce or eliminate these types of  impairments.ä
 |